The United States Irritable Bowel Syndrome (IBS) Market and Competitive Landscape (2014-2024) - ResearchAndMarkets.com

DUBLIN--()--The "US Irritable Bowel Syndrome Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

US Irritable Bowel Syndrome Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Irritable Bowel Syndrome pipeline products, Irritable Bowel Syndrome epidemiology, Irritable Bowel Syndrome market valuations and forecast, Irritable Bowel Syndrome drugs sales and competitive landscape in the US.

The research is classified into seven sections - Irritable Bowel Syndrome treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Irritable Bowel Syndrome pipeline: Find out the products in clinical trials for the treatment of Irritable Bowel Syndrome by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Irritable Bowel Syndrome epidemiology: Find out the number of patients diagnosed (prevalence) with Irritable Bowel Syndrome in the US
  • Irritable Bowel Syndrome drugs: Identify key products marketed and prescribed for Irritable Bowel Syndrome in the US, including trade name, molecule name, and company
  • Irritable Bowel Syndrome drugs sales: Find out the sales revenues of Irritable Bowel Syndrome drugs in the US
  • Irritable Bowel Syndrome market valuations: Find out the market size for Irritable Bowel Syndrome drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
  • Irritable Bowel Syndrome drugs market share: Find out the market shares for key Irritable Bowel Syndrome drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Irritable Bowel Syndrome market analysis and sales trends
  • Track competitor drugs sales and market share in the US Irritable Bowel Syndrome market
  • Track competitive developments in Irritable Bowel Syndrome market and present key issues and learnings
  • Synthesize insights for Irritable Bowel Syndrome market and products to drive business performance
  • Answer key business questions about the Irritable Bowel Syndrome market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Irritable Bowel Syndrome products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered

1) Irritable Bowel Syndrome Treatments

2) Irritable Bowel Syndrome Pipeline

3) US Irritable Bowel Syndrome Epidemiology

4) Marketed Drugs for Irritable Bowel Syndrome in US

5) US Irritable Bowel Syndrome Market Size and Forecast

6) US Irritable Bowel Syndrome Products Sales and Forecast

7) US Irritable Bowel Syndrome Market Competitive Landscape

8) Methodology

List of Tables

1. Irritable Bowel Syndrome Phase 3 Clinical Trials, 2019

2. Irritable Bowel Syndrome Phase 2 Clinical Trials, 2019

3. Irritable Bowel Syndrome Phase 1 Clinical Trials, 2019

4. Irritable Bowel Syndrome Epidemiology, US, 2014 - 2024

5. Marketed Drugs for Irritable Bowel Syndrome, US, 2018

6. Irritable Bowel Syndrome Market Size and Forecast ($), US, 2014 - 2024

7. Irritable Bowel Syndrome Product Sales ($), US, 2014 - 2024

List of Figures

1. Irritable Bowel Syndrome Epidemiology, US, 2014 - 2024

2. Irritable Bowel Syndrome Market Size and Forecast ($), US, 2014 - 2024

3. Irritable Bowel Syndrome Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/9dyf5c

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastrointestinal Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastrointestinal Drugs